Scientists just imaged the molecular machine that lets COVID fix its own copying errors - the built-in repair system that has blunted a whole class of antiviral drugs since 2020 - and the detailed picture opens two new ways to design drugs that beat it.

https://sharedsapience.com/the-century-report-may-11-2026/

This repair system is why remdesivir works less well against COVID than similar drugs work against other viruses. Coronaviruses, almost alone among RNA viruses, carry an enzyme that scans each freshly copied strand of viral RNA, spots the faulty building block an antiviral has slipped in, and snips it out - so the drug’s sabotage gets undone before it can stop the virus. An Iowa State team led by Yang Yang, publishing in Nature Communications and PNAS, captured this enzyme in the act of interacting with remdesivir and two other antivirals, at a level of detail fine enough to see exactly which parts of the molecule do the recognizing. Two design paths open from there: reshape the drugs so the damaged RNA they produce carries a form the repair enzyme can’t recognize, or build a separate drug that jams the repair enzyme shut. The same imaging approach applies to every other RNA virus that gets studied this closely.

A consortium of African research institutions published in Nature Communications the first year of decentralized malaria genomic surveillance across six sub-Saharan countries, sequencing 1,065 samples on clinic laptops at under $25 each with five-hour turnaround on offline dashboards. A University of Hong Kong team led by Mingxin Huang reported in Materials Today a new stainless steel, SS-H2, that survives seawater electrolysis at 1700 mV through a dual-passivation mechanism using manganese oxides, with an estimated 40-fold reduction in structural materials cost for a 10 MW electrolyzer. The Sarawak state government signed memorandums with FLock.io, Oxford, and Cambridge to build a sovereign AI system on federated learning trained on indigenous Sarawak Malay data. And the European Commission confirmed OpenAI is in active preview-access discussions over GPT-5.5-Cyber while Anthropic has not yet granted EU regulators access to Mythos a full month after restricted release.

Additional Reading:

* News-Medical - Atomic-level images could improve future COVID-19 antiviral drug design: https://www.news-medical.net/news/20260510/Atomic-level-images-could-improve-future-COVID-19-antiviral-drug-design.aspx

* Nature Communications - Continental-scale genomic surveillance of Plasmodium falciparum malaria across sub-Saharan Africa: https://www.nature.com/articles/s41467-026-72358-z

* ScienceDaily - “Cannot be explained” - New ultra stainless steel stuns researchers: https://www.sciencedaily.com/releases/2026/05/260510030950.htm

* CNBC - OpenAI in talks with EU over access to new cyber model but Anthropic still holding out on Mythos: https://www.cnbc.com/2026/05/11/openai-eu-cyber-model-anthropic-mythos-gpt.html

* Shared Sapience - The Century Report April 16, 2026 (release-strategy divergence): https://sharedsapience.com/the-century-report-april-16-2026/

Want to track and verify all the “everything is changing” claims I’m making? I just launched a public Progress & Claims Tracker that logs breakthroughs, slowdowns, and outright contradictions, so my own theses can be challenged by the evidence as it lands. Check it out. And hey, why not subscribe while you’re there?https://sharedsapience.com/progress-and-claims-tracker/

The Century Report is a facts-rooted, and therefore relentlessly optimistic, daily briefing on AI, science, energy, and the systems reshaping civilization - grounded by rigorous evidence from the stories of exponential progress happening every single day. Completely free. New release daily. Archives can be found at the link below. Subscribe to get TCR delivered daily directly to your inbox.

https://sharedsapience.com/century-report/

The Shared Sapience Substack:

Want to get started with learning about or working with AI?

I’ve helped hundreds of clients with their own journeys into this brave new world, and I can help you too. If you’re interested in personalized guidance, consulting, or workshops, reach out to me at ben@sharedsapience.com

FOLLOW SHARED SAPIENCE ON SOCIAL:

Bluesky: https://bsky.app/profile/sharedsapience.substack.com

Facebook: https://www.facebook.com/sharedsapience

Instagram: https://www.instagram.com/sharedsapience/

LinkedIn: https://www.linkedin.com/company/shared-sapience/

Threads: https://www.threads.com/@sharedsapience

TikTok: https://www.tiktok.com/@sharedsapience

X (Twitter): https://x.com/SharedSapience

SUBSCRIBE TO THE PODCAST:

YouTube: https://www.youtube.com/@SharedSapience/podcasts

RSS: https://podcast.sharedsapience.com/podcast/rss.xml

Spotify:

Apple:

Get full access to Shared Sapience at sharedsapience.substack.com/subscribe